It's Time to Reassess the High-Density Lipoprotein (HDL) Hypothesis: CSL112, a Novel Promising Reconstituted HDL Formulation

Journal of the American Heart Association

Volumn 4, Issue 8, 2015, Pages e002371-

  Marsche, Gunther ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

ATP binding cassette transporter A1; coronary artery disease; Editorials; high density lipoprotein raising therapies

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; PERIPHERAL VASCULAR DISEASES;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; MALE; PERIPHERAL VASCULAR DISEASES;

EID: 85021389217     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002371     Document Type: Editorial

References (0)